N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, M. Benkirane: SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. In: Nature. Band 474, Nummer 7353, Juni 2011, ISSN1476-4687, S. 654–657, doi:10.1038/nature10117, PMID 21613998, PMC 3595993 (freier Volltext).
K. Hrecka, C. Hao, M. Gierszewska, S. K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M. P. Washburn, J. Skowronski: Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. In: Nature. Band 474, Nummer 7353, Juni 2011, ISSN1476-4687, S. 658–661, doi:10.1038/nature10195, PMID 21720370, PMC 3179858 (freier Volltext).
A. Berger, A. F. Sommer, J. Zwarg, M. Hamdorf, K. Welzel, N. Esly, S. Panitz, A. Reuter, I. Ramos, A. Jatiani, L. C. Mulder, A. Fernandez-Sesma, F. Rutsch, V. Simon, R. König, E. Flory: SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. In: PLoS pathogens. Band 7, Nummer 12, Dezember 2011, ISSN1553-7374, S. e1002425, doi:10.1371/journal.ppat.1002425, PMID 22174685, PMC 3234228 (freier Volltext).
H. Lahouassa, W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue, L. Dragin, N. Bloch, C. Maudet, M. Bertrand, T. Gramberg, G. Pancino, S. Priet, B. Canard, N. Laguette, M. Benkirane, C. Transy, N. R. Landau, B. Kim, F. Margottin-Goguet: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. In: Nature Immunology. Band 13, Nummer 3, März 2012, ISSN1529-2916, S. 223–228, doi:10.1038/ni.2236, PMID 22327569, PMC 3771401 (freier Volltext).
N. Beloglazova, R. Flick, A. Tchigvintsev, G. Brown, A. Popovic, B. Nocek, A. F. Yakunin: Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. In: The Journal of biological chemistry. Band 288, Nummer 12, März 2013, ISSN1083-351X, S. 8101–8110, doi:10.1074/jbc.M112.431148, PMID 23364794, PMC 3605629 (freier Volltext).
J. Ryoo, J. Choi, C. Oh, S. Kim, M. Seo, S. Y. Kim, D. Seo, J. Kim, T. E. White, A. Brandariz-Nuñez, F. Diaz-Griffero, C. H. Yun, J. A. Hollenbaugh, B. Kim, D. Baek, K. Ahn: The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. In: Nature medicine. Band 20, Nummer 8, August 2014, ISSN1546-170X, S. 936–941, doi:10.1038/nm.3626, PMID 25038827, PMC 4318684 (freier Volltext).
T. E. White, A. Brandariz-Nuñez, J. C. Valle-Casuso, S. Amie, L. A. Nguyen, B. Kim, M. Tuzova, F. Diaz-Griffero: The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. In: Cell host & microbe. Band 13, Nummer 4, April 2013, ISSN1934-6069, S. 441–451, doi:10.1016/j.chom.2013.03.005, PMID 23601106, PMC 3864637 (freier Volltext).
Z. Chen, L. Zhang, S. Ying: SAMHD1: a novel antiviral factor in intrinsic immunity. In: Future microbiology. Band 7, Nummer 9, September 2012, ISSN1746-0921, S. 1117–1126, doi:10.2217/fmb.12.81, PMID 22953710.
nih.gov
ncbi.nlm.nih.gov
N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, M. Benkirane: SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. In: Nature. Band 474, Nummer 7353, Juni 2011, ISSN1476-4687, S. 654–657, doi:10.1038/nature10117, PMID 21613998, PMC 3595993 (freier Volltext).
K. Hrecka, C. Hao, M. Gierszewska, S. K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M. P. Washburn, J. Skowronski: Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. In: Nature. Band 474, Nummer 7353, Juni 2011, ISSN1476-4687, S. 658–661, doi:10.1038/nature10195, PMID 21720370, PMC 3179858 (freier Volltext).
A. Berger, A. F. Sommer, J. Zwarg, M. Hamdorf, K. Welzel, N. Esly, S. Panitz, A. Reuter, I. Ramos, A. Jatiani, L. C. Mulder, A. Fernandez-Sesma, F. Rutsch, V. Simon, R. König, E. Flory: SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. In: PLoS pathogens. Band 7, Nummer 12, Dezember 2011, ISSN1553-7374, S. e1002425, doi:10.1371/journal.ppat.1002425, PMID 22174685, PMC 3234228 (freier Volltext).
H. Lahouassa, W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue, L. Dragin, N. Bloch, C. Maudet, M. Bertrand, T. Gramberg, G. Pancino, S. Priet, B. Canard, N. Laguette, M. Benkirane, C. Transy, N. R. Landau, B. Kim, F. Margottin-Goguet: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. In: Nature Immunology. Band 13, Nummer 3, März 2012, ISSN1529-2916, S. 223–228, doi:10.1038/ni.2236, PMID 22327569, PMC 3771401 (freier Volltext).
N. Beloglazova, R. Flick, A. Tchigvintsev, G. Brown, A. Popovic, B. Nocek, A. F. Yakunin: Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. In: The Journal of biological chemistry. Band 288, Nummer 12, März 2013, ISSN1083-351X, S. 8101–8110, doi:10.1074/jbc.M112.431148, PMID 23364794, PMC 3605629 (freier Volltext).
J. Ryoo, J. Choi, C. Oh, S. Kim, M. Seo, S. Y. Kim, D. Seo, J. Kim, T. E. White, A. Brandariz-Nuñez, F. Diaz-Griffero, C. H. Yun, J. A. Hollenbaugh, B. Kim, D. Baek, K. Ahn: The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. In: Nature medicine. Band 20, Nummer 8, August 2014, ISSN1546-170X, S. 936–941, doi:10.1038/nm.3626, PMID 25038827, PMC 4318684 (freier Volltext).
T. E. White, A. Brandariz-Nuñez, J. C. Valle-Casuso, S. Amie, L. A. Nguyen, B. Kim, M. Tuzova, F. Diaz-Griffero: The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. In: Cell host & microbe. Band 13, Nummer 4, April 2013, ISSN1934-6069, S. 441–451, doi:10.1016/j.chom.2013.03.005, PMID 23601106, PMC 3864637 (freier Volltext).
Z. Chen, L. Zhang, S. Ying: SAMHD1: a novel antiviral factor in intrinsic immunity. In: Future microbiology. Band 7, Nummer 9, September 2012, ISSN1746-0921, S. 1117–1126, doi:10.2217/fmb.12.81, PMID 22953710.
zdb-katalog.de
N. Laguette, B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, M. Benkirane: SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. In: Nature. Band 474, Nummer 7353, Juni 2011, ISSN1476-4687, S. 654–657, doi:10.1038/nature10117, PMID 21613998, PMC 3595993 (freier Volltext).
K. Hrecka, C. Hao, M. Gierszewska, S. K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M. P. Washburn, J. Skowronski: Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. In: Nature. Band 474, Nummer 7353, Juni 2011, ISSN1476-4687, S. 658–661, doi:10.1038/nature10195, PMID 21720370, PMC 3179858 (freier Volltext).
A. Berger, A. F. Sommer, J. Zwarg, M. Hamdorf, K. Welzel, N. Esly, S. Panitz, A. Reuter, I. Ramos, A. Jatiani, L. C. Mulder, A. Fernandez-Sesma, F. Rutsch, V. Simon, R. König, E. Flory: SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. In: PLoS pathogens. Band 7, Nummer 12, Dezember 2011, ISSN1553-7374, S. e1002425, doi:10.1371/journal.ppat.1002425, PMID 22174685, PMC 3234228 (freier Volltext).
H. Lahouassa, W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue, L. Dragin, N. Bloch, C. Maudet, M. Bertrand, T. Gramberg, G. Pancino, S. Priet, B. Canard, N. Laguette, M. Benkirane, C. Transy, N. R. Landau, B. Kim, F. Margottin-Goguet: SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. In: Nature Immunology. Band 13, Nummer 3, März 2012, ISSN1529-2916, S. 223–228, doi:10.1038/ni.2236, PMID 22327569, PMC 3771401 (freier Volltext).
N. Beloglazova, R. Flick, A. Tchigvintsev, G. Brown, A. Popovic, B. Nocek, A. F. Yakunin: Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. In: The Journal of biological chemistry. Band 288, Nummer 12, März 2013, ISSN1083-351X, S. 8101–8110, doi:10.1074/jbc.M112.431148, PMID 23364794, PMC 3605629 (freier Volltext).
J. Ryoo, J. Choi, C. Oh, S. Kim, M. Seo, S. Y. Kim, D. Seo, J. Kim, T. E. White, A. Brandariz-Nuñez, F. Diaz-Griffero, C. H. Yun, J. A. Hollenbaugh, B. Kim, D. Baek, K. Ahn: The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. In: Nature medicine. Band 20, Nummer 8, August 2014, ISSN1546-170X, S. 936–941, doi:10.1038/nm.3626, PMID 25038827, PMC 4318684 (freier Volltext).
T. E. White, A. Brandariz-Nuñez, J. C. Valle-Casuso, S. Amie, L. A. Nguyen, B. Kim, M. Tuzova, F. Diaz-Griffero: The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. In: Cell host & microbe. Band 13, Nummer 4, April 2013, ISSN1934-6069, S. 441–451, doi:10.1016/j.chom.2013.03.005, PMID 23601106, PMC 3864637 (freier Volltext).
Z. Chen, L. Zhang, S. Ying: SAMHD1: a novel antiviral factor in intrinsic immunity. In: Future microbiology. Band 7, Nummer 9, September 2012, ISSN1746-0921, S. 1117–1126, doi:10.2217/fmb.12.81, PMID 22953710.